|

Sotatercept Clinical Trials

2 actively recruiting trials across 1 location

Also known as: ACE-011

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Merck Sharp & Dohme LLC1
  • Kazuya Hosokawa1

Indications

  • Heart Disease2
  • Pulmonary Arterial Hypertension of Congenital Heart Disease1
  • Eisenmenger Syndrome1
  • Hypertension, Pulmonary1

Other1 trial

A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
Phase 4

Phoenix, Arizona1 trial

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

Pulmonary Associates, PA ( Site 1008)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.